where do we go from now, page-2

Hi Mike,

So I score cce as 1 out of 8 on your checklist.

1. Successful products on the market - no. Not commercially successful & possibly not successful as a treatment, judging by sales.

2. A deep product pipeline with late-stage candidates - no. Three branded products, but all the same really (only ReCell available now)

3. Drugs and candidates that target large or underserved markets - yes, I guess

4. Partnerships and marketing agreements with blue-chip drug manufacturers - no

5. Research & development spending - no

6. Enough cash to fund operations for two years - no

7. Experienced management - no (the old management has proved to be very poor so far)

8. Favorable financial analysis - no